The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with ...
The tickets could go to the lipid-lowering pill enlicitide decanoate and the antibody-drug conjugate sacituzumab tirumotecan, ...
The FDA taps J&J drug teclistamab for its National Priority Voucher pilot, enabling expedited review for multiple myeloma treatment.
The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten ...
FDA grants 1st approval under priority voucher program to Augmentin XR, expediting review and supporting U.S. antibiotic supply chain resilience.
Saol Therapeutics received a complete response letter for its pyruvate dehydrogenase complex deficiency treatment a week ...
The Food and Drug Administration has launched a new transparency policy for the reporting of foodborne illness outbreak investigations. As part of the initiative the public, industry stakeholders and ...
In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical ...
FDA commissioner Dr. Marty Makary is beginning to make moves toward his promise of speeding up drug approval pathways at the agency. But he’s aiming to do things a bit differently than in the past — ...
FDA has expanded its early alert pilot program to cover all medical devices, according to a September 29 notice. In November 2024, the FDA’s Center for Devices and Radiological Health launched the ...